[1] Abdallah B, Hassan A, Benoist C, et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethyleneimine [J]. Hum Gene Ther, 1996, 7(16):1947-1954. [2] Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly-(ethylenimine) as a gene delivery vehicle [J]. J Biomed Mater Res, 1999, 45(3): 268-275. [3] Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity [J]. Nat Rev Immunol, 2003, 3(10): 791-800. [4] Lai KN, Leung JC, Metz CN, et al. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome [J]. J Pathol, 2003,199(4): 496-508. [5] Gando S, Sawamura A, Hayakawa M, et al. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation[J]. Inflammation, 2007, 30(3/4): 118-124. [6] Chagnon F, Metz CN, Bucala R, et al. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization [J]. Circ Res, 2005, 96 (10): 1095-1102. [7] 江永南, 莫红缨, 陈建海. 聚乙烯亚胺-胆固醇结合脂质微泡介导的基因转染系统[J].药学学报, 2010, 45 (5): 659-666. [8] Blackwell TS, Blackwell TR, Holden EP, et al. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation[J]. J Immunol, 1996, 157 (4): 1630-1637. [9] 莫红缨, 钟南山, 郑劲平,等. N-乙酰半胱氨酸对急慢性吸烟大鼠肺组织和肺泡灌洗液中核因子NF-κB表达的影响[J]. 中国临床药理学与治疗学, 2001, 6(2) : 103-106. [10] Abraham E. NF- kappa B activation [J]. Crit Care Med, 2000, 28(4): N100-N104. [11] Groesdonk HV, Wagner F, Hoffarth B, et al. Enhancement of NF-kappaB activation in lymphocytes prevents T cell apoptosis and improves survival in murine sepsis[J]. J Immunol, 2007, 179(12): 8083-8089. [12] Shen YY, Gao ZG, Rapoport N. Recent advances in the applications of ultrasonic microbubbles as gene or drug vectors [J]. Acta Pharm Sin, 2009, 44(9): 961-966. |